New Jersey Pharma Research Company
Research Organization Overview
Organization: New Jersey Pharma Research Company (Founded 2014)
Campaign Duration: 20 Months
Service Focus: Phase I-IV Clinical Trials, CRO Services, Regulatory Affairs Consulting, Biostatistics, Medical Writing, Patient Recruitment
Research Team: 45 Clinical Research Associates, 12 PharmD/MD Investigators, 8 Biostatisticians, 15 Regulatory Specialists
Facility Locations: Princeton NJ, Parsippany NJ, Newark NJ
Annual Trial Volume: 120+ Active Clinical Studies Across All Phases
Capabilities: GCP-Compliant Facilities, FDA Inspection Ready, Electronic Data Capture, Central IRB Services
The New Jersey Pharmaceutical Corridor Challenge
Competing in New Jersey’s dense pharmaceutical research ecosystem against major CROs like Covance and IQVIA while serving Big Pharma sponsors seeking specialized clinical trial expertise, navigating complex FDA regulatory requirements, and establishing credibility in oncology, CNS, and rare disease therapeutic areas across the Garden State’s pharma corridor.
Clinical Research Service Line Performance
Phase I-III Clinical Trials
Dominated NJ clinical trial searches with GCP-compliant Phase I-III study management, FDA regulatory expertise, and end-to-end CRO services for pharmaceutical sponsors.
Oncology & Rare Disease Trials
Built authority in specialized therapeutic areas with oncology trial expertise, orphan drug development, and complex patient population recruitment strategies.
Regulatory Affairs Consulting
Captured FDA submission searches with IND/NDA preparation, regulatory strategy consulting, and compliance advisory for New Jersey pharmaceutical companies.
Patient Recruitment & Retention
Positioned as leader in clinical trial enrollment with multichannel recruitment strategies, patient databases, and retention protocols across Northeast region.
Client & Sponsor Distribution
Large Pharmaceutical
Top 20 pharma company sponsors
Biotech Companies
Emerging biotech sponsors
Academic Medical Centers
University-sponsored trials
CRO Collaborations
Strategic CRO partnerships
New Jersey Pharma Corridor Advantages
Leveraging unique Garden State pharmaceutical research ecosystem:
Revenue & Growth Metrics
Additional Revenue
20-Month Period
Average Trial Value
Per Clinical Study
Protocol Adherence
GCP Compliance Rate
Research Professionals
CRA & Regulatory Team
Visibility Improvement Against New Jersey CRO Competitors
Successfully enhanced search presence against major pharmaceutical research organizations:
Campaign Timeline & Market Development Milestones
NJ Pharma Corridor Market Analysis
Comprehensive research of New Jersey pharmaceutical landscape, sponsor decision-making criteria, therapeutic area trends, and competitive CRO positioning analysis.
Therapeutic Area Expertise Content
Developed specialized clinical trial content on oncology studies, CNS research, rare disease protocols, and regulatory pathway guidance for pharmaceutical sponsors.
FDA Regulatory Authority Building
Enhanced visibility in regulatory consulting with IND/NDA submission guides, FDA meeting preparation content, and compliance best practices for New Jersey biotech.
Clinical Trial Excellence Positioning
Established dominance in Phase I-IV trial management with GCP compliance documentation, sponsor case studies, enrollment metrics, and quality assurance protocols.
Comprehensive Clinical Research Excellence
Advanced Research Capabilities: GCP-compliant clinical trial facilities with FDA inspection readiness, electronic data capture systems, central IRB coordination, and comprehensive pharmacovigilance. Expert clinical research associates, regulatory affairs specialists, biostatisticians, and medical writers providing end-to-end CRO services from protocol development through NDA submission with specialization in oncology, CNS disorders, rare diseases, and complex therapeutic areas.
Strategic Pharmaceutical Research SEO Initiatives
Therapeutic Area Specialization
Built deep expertise content in oncology trials, CNS research, rare disease studies, and orphan drug development targeting New Jersey pharmaceutical sponsor needs.
Regulatory Consulting Authority
Established FDA regulatory expertise with IND/NDA preparation guides, 505(b)(2) pathway content, and regulatory strategy consulting for Garden State biotech companies.
GCP Compliance Leadership
Positioned as quality standard leader with GCP training resources, FDA inspection preparation, audit readiness protocols, and compliance best practices documentation.
Patient Recruitment Excellence
Developed comprehensive enrollment strategies with diverse patient databases, multichannel recruitment, retention protocols, and Northeast regional access for sponsors.
Biostatistics & Data Management
Enhanced analytical services visibility with statistical analysis planning, adaptive trial designs, EDC systems expertise, and clinical data management for complex studies.
Medical Writing Services
Captured regulatory writing searches with CSR preparation, protocol development, investigator brochures, and regulatory submission document expertise for NJ pharma.
High-Value Clinical Research Keywords
Successfully captured top rankings for critical pharmaceutical research and CRO search terms: